## EG: Everest Group, Ltd. - XLF: Financial Services

### Executive Summary

STRENGTH thesis confirmed: MRS_10 at 4.4% in lower entry zone (3.0-6.0%), top 9% cross-sectional ranking. Short-term MRS_5 (1.8%) confirms momentum alignment. Strong momentum (+4.2% 5-day acceleration).

- **Horizon:** 5-20 days (swing)
- **Risk Profile:** Moderate - momentum continuation
- **Stop Type:** Fixed 2xATR ($314.54)
- **If Wrong:** Exit if MRS_10 drops below entry zone or breaks stop
- **Invalidation:** MRS_10 exits entry zone or MRS_5 turns negative

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. AIG secures renewal rights for Everest Group retail portfolios in EU**
- Source: Insurance Business | 20251216T023604 | Neutral | Relevance: 100%
- AIG has received regulatory approval to acquire the renewal rights for a majority of Everest Group's retail insurance portfolios in EU countries, following a deal announced in October for $300 million. This transaction, representing about $2 billion of global premium, allows AIG to expand its retail insurance book and strengthen its presence in key global markets without significantly increasing costs or capital requirements. AIG will assume renewal capacity for eligible policies starting January 1, 2026, with Everest Group retaining liability exposure and claims administration.

**2. Mizuho initiates Everest Group stock coverage with Neutral rating By Investing.com**
- Source: Investing.com Australia | 20251216T000804 | Somewhat-Bearish | Relevance: 100%
- Mizuho has initiated coverage on Everest Group (NYSE:EG) with a Neutral rating and a price target of $359.00, citing concerns over the company's history of reserve strengthening and recent retrenchment in its Insurance operations. Despite these challenges, Everest Group maintains a 2.45% dividend yield and has sustained dividend payments for 31 consecutive years, though analysts anticipate a sales decline and potential premium pressure. The firm also highlighted Everest's strategic pivot towards Reinsurance, departing from its prior focus on higher-multiple specialty insurance.

**3. TD Cowen Cuts Everest Group (NYSE:EG) Price Target to $365.00**
- Source: MarketBeat | 20251215T173207 | Somewhat-Bearish | Relevance: 100%
- TD Cowen reduced its price target for Everest Group (NYSE:EG) to $365.00 from $400.00 while maintaining a "hold" rating, suggesting a 12.36% upside. This adjustment follows Everest Group's recent earnings miss, reporting $7.54 EPS against an expected $13.39, despite beating revenue estimates with $4.32 billion. Analyst consensus for Everest Group is a "Hold" with an average target price of $368.50.

**4. TD Cowen Lowers Price Target for Everest Group (EG) to $365 | EG Stock News**
- Source: GuruFocus | 20251215T170907 | Somewhat-Bearish | Relevance: 100%
- TD Cowen has lowered its price target for Everest Group (EG) to $365 from $400, while maintaining a "Hold" rating for the stock. This adjustment reflects a cautious stance amid market conditions, following similar price target reductions by other financial analysts in recent months. Despite the lowered target, the average analyst forecast still suggests an upside for EG from its current price.

**5. How is Everest Group's stock performance compared to other insurance stocks?**
- Source: MSN | 20251214T190811 | Neutral | Relevance: 100%
- The article discusses Everest Group's stock performance relative to its peers in the insurance industry. It likely provides a comparative analysis of key metrics such as stock price, returns, and perhaps financial health indicators against other insurance companies. Further details would be needed from the full article to provide a more specific summary.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-16 | Mizuho | $359 | $0 | 0% |
| 2025-12-15 | TD Cowen | $365 | $400 | -9% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-16 | Mizuho | init | Neutral |
| 2025-12-15 | TD Cowen | main | Hold |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 44.1% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 3 / 6 |

**Top Holders:**
- Vanguard Group Inc: 13.1% (-1.0%)
- Blackrock Inc.: 8.1% (-2.9%)
- AQR Capital Manageme: 4.8% (+70.3%)
- State Street Corpora: 4.5% (-0.7%)
- Vulcan Value Partner: 3.4% (+13.9%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Momentum building: MRS_10 improving +4.2% over 5 days suggests accumulation.

### Fundamentals

Forward P/E 5.9x attractive for 24% earnings growth. Balance sheet: strong liquidity (11.3x). Revenue declining -6% YoY, concerning. Analyst sentiment negative (1 target cuts vs 0 raises). Institutional flow bullish (3 buying vs 6 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $13.7B |
| Beta | 0.38 |
| 52W Range | $302.44 - $373.23 |
| Short Interest | 2.3% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | -50.00 |
| Forward P/E | 5.9 |
| Current P/E | 7.3 |
| YoY Growth | 24.0% |
| EPS Direction | STABLE |

### Technicals

MRS_10 strengthening from 0.2% to 4.4% (+4.2% in 5 days), confirming momentum buildup. Currently in lower STRENGTH zone (3.0-6.0%), cross-sectional ranking at 91st percentile. MRS_5 at 1.8% confirms short-term momentum alignment. Below SMA200 (0.96x), long-term trend not supportive. MACD histogram positive (2.79), confirming momentum. RSI neutral at 59. OFD pattern: -SLN (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 4.38% (CS: 91) | Strong |
| RSI_14 | 58.7 | Neutral |
| MACD Histogram | 2.79 | Bullish |
| vs SMA20 | 1.039x | Above |
| vs SMA50 | 1.001x | Above |
| vs SMA200 | 0.964x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** STRENGTH

### Trade Setup

- **Entry:** $327.50
- **Stop Loss:** $314.54 (4.0% risk)
- **Target:** $346.94 (R:R method)
- **Risk/Reward:** 1.50:1
- **Target Reasoning:** STRENGTH thesis targets 1.5x risk/reward based on historical edge

### Position Sizing

- **Shares:** 92
- **Position Value:** $30,130.00
- **Portfolio %:** 30.13%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | MOMENTUM (Zone F) | 1.20x |

*NORMAL regime with balanced risk positioning. VIX remains calm at 16.48 while breadth shows modest improvement to 52%, indicating neither euphoria nor distress. Mixed sectoral themes from energy weakness to AI expansion suggest stock-picking environment rather than broad directional moves.*

### Earnings

**Next:** 2026-02-02 (Est: $13.08)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $14.52 | $7.54 | -48.1% |
| 2025Q2 | $14.82 | $17.36 | +17.1% |
| 2025Q1 | $7.74 | $6.45 | -16.7% |
| 2024Q4 | $-17.42 | $-18.39 | -5.6% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*